Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis and current skin involvement: A phase III, randomised, controlled trial (PALACE 3)

  1. Edwards, C.J.
  2. Blanco, F.J.
  3. Crowley, J.
  4. Birbara, C.A.
  5. Jaworski, J.
  6. Aelion, J.
  7. Stevens, R.M.
  8. Vessey, A.
  9. Zhan, X.
  10. Bird, P.
Revista:
Annals of the Rheumatic Diseases

ISSN: 1468-2060,  0003-4967

Ano de publicación: 2016

Volume: 75

Número: 6

Páxinas: 1065-1073

Tipo: Artigo

DOI: 10.1136/ANNRHEUMDIS-2015-207963 GOOGLE SCHOLAR lock_openAcceso aberto editor
Fonte de datos: Scopus